Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
190
NCT03745001
To Evaluate the Safety and Tolerability, Pharmacokinetics, Food-effect and Pharmacodynamics of EHP-101 in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 14, 2018
Completion: Sep 13, 2019
NCT04166552
Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Diffuse Cutaneous Systemic Sclerosis
Phase: Phase 2
Start: Jun 11, 2020
Completion: Oct 31, 2024
NCT04909502
Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Relapsing Forms of Multiple Sclerosis
Start: Oct 19, 2021
Completion: Apr 30, 2024